FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116563692> ?p ?o ?g. }

• W2116563692 endingPage "717" @default.
• W2116563692 startingPage "711" @default.
• W2116563692 abstract "It remains unclear why some individuals are susceptible to excitotoxicity after stroke. A possible explanation is impaired glutamate uptake. We have found a highly prevalent polymorphism in the promoter of the glutamate transporter EAAT2 gene that abolishes a putative regulatory site for activator protein-2 (AP-2) and creates a new consensus binding site for the repressor transcription factor GC-binding factor 2 (GCF2). The mutant genotype is associated with increased plasma glutamate concentrations and with a higher frequency of early neurological worsening in human stroke. After transfection into astrocytes, the mutant promoter was not activated by AP-2 and was effectively repressed by GCF2, and its activity in the presence of GCF2 was reduced when compared with the AP-2-cotransfected wild-type promoter. We also show that GCF2 is expressed in ischemic rat brain, suggesting that decreased glutamate uptake occurs in individuals carrying the mutation after stroke. These findings may explain individual susceptibility to excitotoxic damage after stroke as well as the failure of glutamate antagonists in those patients without this polymorphism." @default.
• W2116563692 created "2016-06-24" @default.
• W2116563692 creator A5007229858 @default.
• W2116563692 creator A5016967825 @default.
• W2116563692 creator A5019880814 @default.
• W2116563692 creator A5020184761 @default.
• W2116563692 creator A5021227220 @default.
• W2116563692 creator A5023964420 @default.
• W2116563692 creator A5053373146 @default.
• W2116563692 creator A5059672802 @default.
• W2116563692 creator A5060792245 @default.
• W2116563692 creator A5072885357 @default.
• W2116563692 creator A5090748302 @default.
• W2116563692 date "2006-03-06" @default.
• W2116563692 modified "2023-10-12" @default.
• W2116563692 title "A polymorphism in the <i>EAAT2</i> promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke" @default.
• W2116563692 cites W1532205670 @default.
• W2116563692 cites W1571471661 @default.
• W2116563692 cites W1887210332 @default.
• W2116563692 cites W1976366566 @default.
• W2116563692 cites W1987520241 @default.
• W2116563692 cites W1991701465 @default.
• W2116563692 cites W1992878798 @default.
• W2116563692 cites W1993331896 @default.
• W2116563692 cites W1996589674 @default.
• W2116563692 cites W1996802760 @default.
• W2116563692 cites W2002646124 @default.
• W2116563692 cites W2003455329 @default.
• W2116563692 cites W2010529236 @default.
• W2116563692 cites W2011524003 @default.
• W2116563692 cites W2012851706 @default.
• W2116563692 cites W2016575029 @default.
• W2116563692 cites W2021052173 @default.
• W2116563692 cites W2035849908 @default.
• W2116563692 cites W2039849406 @default.
• W2116563692 cites W2042550512 @default.
• W2116563692 cites W2045398367 @default.
• W2116563692 cites W2048841941 @default.
• W2116563692 cites W2051861534 @default.
• W2116563692 cites W2053470162 @default.
• W2116563692 cites W2060802422 @default.
• W2116563692 cites W2075770826 @default.
• W2116563692 cites W2094140335 @default.
• W2116563692 cites W2112365969 @default.
• W2116563692 cites W2121726351 @default.
• W2116563692 cites W2126540114 @default.
• W2116563692 cites W2128744963 @default.
• W2116563692 cites W2144258781 @default.
• W2116563692 cites W2148980073 @default.
• W2116563692 cites W2152567653 @default.
• W2116563692 cites W2160644313 @default.
• W2116563692 cites W2166014740 @default.
• W2116563692 cites W2174668858 @default.
• W2116563692 cites W2292308933 @default.
• W2116563692 cites W2316145923 @default.
• W2116563692 cites W2990007984 @default.
• W2116563692 cites W4210979710 @default.
• W2116563692 cites W62247276 @default.
• W2116563692 doi "https://doi.org/10.1084/jem.20051979" @default.
• W2116563692 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2118230" @default.
• W2116563692 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16520390" @default.
• W2116563692 hasPublicationYear "2006" @default.
• W2116563692 type Work @default.
• W2116563692 sameAs 2116563692 @default.
• W2116563692 citedByCount "93" @default.
• W2116563692 countsByYear W21165636922012 @default.
• W2116563692 countsByYear W21165636922013 @default.
• W2116563692 countsByYear W21165636922014 @default.
• W2116563692 countsByYear W21165636922015 @default.
• W2116563692 countsByYear W21165636922016 @default.
• W2116563692 countsByYear W21165636922017 @default.
• W2116563692 countsByYear W21165636922018 @default.
• W2116563692 countsByYear W21165636922019 @default.
• W2116563692 countsByYear W21165636922020 @default.
• W2116563692 countsByYear W21165636922021 @default.
• W2116563692 countsByYear W21165636922022 @default.
• W2116563692 crossrefType "journal-article" @default.
• W2116563692 hasAuthorship W2116563692A5007229858 @default.
• W2116563692 hasAuthorship W2116563692A5016967825 @default.
• W2116563692 hasAuthorship W2116563692A5019880814 @default.
• W2116563692 hasAuthorship W2116563692A5020184761 @default.
• W2116563692 hasAuthorship W2116563692A5021227220 @default.
• W2116563692 hasAuthorship W2116563692A5023964420 @default.
• W2116563692 hasAuthorship W2116563692A5053373146 @default.
• W2116563692 hasAuthorship W2116563692A5059672802 @default.
• W2116563692 hasAuthorship W2116563692A5060792245 @default.
• W2116563692 hasAuthorship W2116563692A5072885357 @default.
• W2116563692 hasAuthorship W2116563692A5090748302 @default.
• W2116563692 hasBestOaLocation W21165636921 @default.
• W2116563692 hasConcept C101762097 @default.
• W2116563692 hasConcept C104317684 @default.
• W2116563692 hasConcept C126322002 @default.
• W2116563692 hasConcept C134018914 @default.
• W2116563692 hasConcept C143065580 @default.
• W2116563692 hasConcept C150194340 @default.
• W2116563692 hasConcept C153911025 @default.
• W2116563692 hasConcept C158448853 @default.
• W2116563692 hasConcept C170493617 @default.

• next